Publication:
Synthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis

dc.contributor.authorGultekin, Ergun
dc.contributor.authorBEKİRCAN, OLCAY
dc.contributor.authorKOLCUOĞLU, YAKUP
dc.contributor.authorAKDEMİR, ATİLLA
dc.contributor.institutionauthorAKDEMİR, ATİLLA
dc.date.accessioned2021-05-04T20:59:05Z
dc.date.available2021-05-04T20:59:05Z
dc.date.issued2021-04-01T00:00:00Z
dc.description.abstractTyrosinase inhibition is very important in controlling melanin synthesis. If melanin synthesis is not controlled in metabolism, an unwanted increase in melanin synthesis occurs. As melanin plays a role in the formation of skin color, its unusual levels cause some skin disorders such as pregnancy scars, age spots, and especially skin cancer (melanoma). However, the tyrosinase activity is also related to Parkinson-s disease and some neurodegenerative diseases. For all these reasons, the medicinal as well as the cosmetic industries focus on research on tyrosinase inhibitors for the treatment of skin disorders and some neurodegenerative diseases. In this study, 32 new 1,2,4-triazole-(thio)semicarbazide hybrid molecules (6a-p and 7a-p) were synthesized, starting from 4-amino-1-pentyl-3-phenyl-1H-1,2,4-triazole-5(4H)-one. These compounds were evaluated for their inhibitory activity against mushroom tyrosinase. The results indicated that 6h, 6m, 6n, and 6p exhibited the most effective inhibitory activity, with IC50 values of 0.00162 +/- 0.0109, 0.00166 +/- 0.0217, 0.00165 +/- 0.019, and 0.00197 +/- 0.0063 mu M, respectively, compared with kojic acid as the reference drug (IC50 = 14.09 +/- 0.02 mu M). Also, molecular docking analyses were performed to suggest possible binding poses for the ligands. As a result, derivatives 6h, 6m, 6n, and 6p can be used as promising tyrosinase inhibitor candidates in the medicinal, cosmetics, or food industries.
dc.identifier.citationGultekin E., BEKİRCAN O., KOLCUOĞLU Y., AKDEMİR A., -Synthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis-, ARCHIV DER PHARMAZIE, 2021
dc.identifier.doi10.1002/ardp.202100058
dc.identifier.pubmed33900640
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28834
dc.identifier.wosWOS:000643900400001
dc.titleSynthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis
dc.typeArticle
dspace.entity.typePublication
local.avesis.id13064257-5d9f-4615-8eb8-e15b53566d51
local.indexed.atPubMed
local.indexed.atWOS
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication19bc513a-c695-4e72-ba1d-83b8d6c574c8
relation.isAuthorOfPublication.latestForDiscovery19bc513a-c695-4e72-ba1d-83b8d6c574c8
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files